U.S. Point-of-Care Diagnostics Market Set to Reach $13.16 Billion by 2030 Meticulous Research® Unveils Comprehensive Insights in Latest Report on U.S. Point-of-Care Diagnostics Market Meticulous Research®, a prominent global market research firm, has released an in-depth research report titled, "U.S. Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker), Platform (LFA, Molecular), Sample (Blood, Urine), End User - Forecast to 2030." Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730 Market Dynamics The report underscores the pivotal role of innovation in POC tests, emphasizing the growing commercialization of CLIA-waived POC tests. Furthermore, the surge in funding for research and development, the rise in awareness regarding early disease diagnosis, and the increasing prevalence of chronic diseases are key drivers fueling the U.S. point-of-care diagnostics market. Despite these positive factors, the market faces challenges in the form of stringent regulatory policies and pricing pressures resulting from reimbursement fluctuations. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/us-point-of-care-diagnostics-market-5730 Key Players Shaping the Market The report highlights key players influencing the U.S. point-of-care diagnostics market, including Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), QuidelOrtho Corporation (U.S.), Sekisui Diagnostics, LLC. (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), and Nova Biomedical (U.S.). Future Outlook Have Any Query ? Speak To Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5730 For further insights and a detailed analysis, please refer to the complete "U.S. Point-of-Care Diagnostics Market by Meticulous Research® – Forecast to 2030" report. Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730 Related Research: 1. Point of care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Global Forecast to 2030 https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871 2. Asia-Pacific Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Forecast to 2030 https://www.meticulousresearch.com/product/asia-pacific-point-of-care-diagnostics-market-5671 3. Europe Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis) Platform (LFA, Molecular) Sample, and End User - Forecast to 2030 https://www.meticulousresearch.com/product/europe-point-of-care-diagnostics-market-5650

Veterinary Point of Care Diagnostics Market Research's Role in Driving Revenue Growth Global Veterinary Point of Care Diagnostics Market Research Report and Forecast is an investigative report providing an extensive study of the global Veterinary Point of Care Diagnostics market with regards to market size, market share, current and emerging trends, and latest technological developments. The report also sheds light on the competitive landscape of the Veterinary Point of Care Diagnostics market on the global and regional scale, along with a thorough forecast estimation. https://www.emergenresearch.com/industry-report/veterinary-point-of-care-diagnostics-market

According to a new market research report titled, ‘Africa In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User — Forecast to 2030,’ published by Meticulous Research®, the Africa in vitro diagnostics market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030. Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5415 High Prevalence of Infectious Diseases Driving the Growth of the Africa IVD Market Diagnostic tests are crucial in the medical care of patients with infections. The demand for IVD kits used to diagnose infectious diseases is high in Africa due to the increasing awareness regarding emerging and re-emerging infectious diseases and the adoption of advanced molecular testing and lab-on-chip technology. The burden of diseases such as HIV, tuberculosis, malaria, viral hepatitis, and neglected tropical diseases (NTDs) is large in Africa. For example, according to WHO, in 2020, 25.6 million people were living with HIV in the African Region. The annual number of new HIV infections increased in the Middle East and North Africa (source: UNAIDS data 2021). In addition, there is a frequent outbreak of endemic diseases in Africa. For instance, Lassa fever is endemic in Nigeria and continues to be reported nationwide, according to Nigeria Centre for Disease Control and Prevention (NCDC). In January 2022, 981 suspected and 211 confirmed cases of Lassa fever were reported in Nigeria. There were 40 deaths reported among confirmed cases, indicating a case fatality rate of 19%. Thus, the high burden of infectious diseases increases the demand for IVD tests in Africa. Africa IVD Market Outlook The Africa IVD market is segmented based on Product Category (Reagents, & Kits, Instruments, and Software & Services), Technology (Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Microbiology, Coagulation & Hemostasis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, Point-of-care Testing, and OTC/Self-testing), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Healthcare, and Other End Users), and Geography (South Africa, Egypt, Nigeria, Kenya, Algeria, Tanzania, Morocco, Tunisia, and the rest of Africa). The study also evaluates industry competitors and analyzes their market shares. Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5415 Quick Buy – Africa IVD Market - Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/47708335